Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | MITF | O75030 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL992584 | 0.78 | SMN1; SMN2 (0.33) | SMN1; SMN2TDP1ALDH1A1L3MBTL1 | |
| SCHEMBL6824552 | 0.77 | MAPK1 (0.36) | SMN1; SMN2KMT2ATDP1ALDH1A1 | |
| SCHEMBL6818549 | 0.73 | ALDH1A1 (0.40) | SMN1; SMN2KMT2ATDP1LMNAHPGD | |
| SCHEMBL22493942 | 0.61 | EHMT2 (0.50) | SMN1; SMN2KMT2ALMNANPSR1ALDH1A1 | |
| SCHEMBL22518781 | 0.61 | EHMT2 (0.50) | SMN1; SMN2KMT2ALMNANPSR1ALDH1A1 | |
| SCHEMBL21389415 | 0.61 | SMN1; SMN2 (0.31) | RAB9ASMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL21389465 | 0.61 | ALDH1A1 (0.31) | RAB9AKMT2AALDH1A1 | |
| SCHEMBL21389463 | 0.61 | ALDH1A1 (0.31) | RAB9AKMT2AALDH1A1 | |
| SCHEMBL9893274 | 0.61 | ALDH1A1 (0.35) | RAB9ANPC1MITFSMN1; SMN2KMT2A | |
| SCHEMBL21389274 | 0.59 | MEN1 (0.31) | KMT2AHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7405065-B2 | Such as 1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene via N-acetylamino-alcohol hydrolase isolated from Rhodococcus, Gordona, Arthrobacter, Alcaligenes, Agrobacterium/Rhizobium, Bacillus, Pseudomonas or Alcaligenes/Bordetella | LONZA AG (CH) | 2008-07-29 | — | — | US | disclosed |
| EP-1502914-A1 | Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives | Lonza AG (CH) | 2005-02-02 | — | — | EP | disclosed |
| US-20040265985-A1 | Such as 1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene via N-acetylamino-alcohol hydrolase isolated from Rhodococcus, Gordona, Arthrobacter, Alcaligenes, Agrobacterium/Rhizobium, Bacillus, Pseudomonas or Alcaligenes/Bordetella | BERNEGGER-EGLI CHRISTINE (CH) | 2004-12-30 | — | — | US | disclosed |
| EP-0904348-B1 | PROCESS FOR THE PREPARATION OF AMINO ALCOHOLS AND DERIVATIVES THEREOF | LONZA AG (CH) | 2004-11-24 | — | — | EP | disclosed |
| US-6787347-B2 | MICROORGANISMS FOR USE IN THE GENERATION OF PREFERENTIAL CYCLOPENTENE | LONZA AG (CH) | 2004-09-07 | — | — | US | disclosed |
| EP-0878548-B1 | Multistep process for the preparation of (1S,4R)- and/or (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopentene-1-methanol | LONZA AG (CH) | 2004-09-01 | — | — | EP | disclosed |
| US-20030008360-A1 | Microorganisms for use in the generation of preferential cyclopentene | BERNEGGER-EGLI CHRISTINE (CH) | 2003-01-09 | — | — | US | disclosed |
| US-6368850-B1 | PREPARING 1-AMINO-4-(HYDROXYMETHYL)-2-CYCLOPENTENE AND N-ACETYLAMINO-ALCOHOL HYDROLASE ACTIVITY OBTAINABLE FROM THESE MICROORGANISMS. | LONZA AG (CH) | 2002-04-09 | — | — | US | disclosed |
| US-6262295-B1 | REACTING CYCLOPENTENE-4-CARBOXYLIC ACID WITH AN ACYL HALIDE | LONZA A.G. (CH) | 2001-07-17 | — | — | US | disclosed |
| US-6252112-B1 | MIBCROBIAL HYDROLYSIS OF THE TITLE COMPOUND DERIVATIVE USING ENZYME HAVING N-ACETYLAMINO-ALCOHOL HYDROLASE OR PENICILLIN G ACYLASE ACTIVITY WITH SUBSEQUENT ACYLATION | LONZA A.G., (CH) | 2001-06-26 | — | — | US | disclosed |
| US-6156893-A | Process for the preparation of (1S,4R)- or (1R,4S)- 4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol | LONZA A.G. (CH) | 2000-12-05 | — | — | US | disclosed |
| US-6137007-A | CHEMICAL INTERMEDIATES FOR NUCLEOSIDE, 4-2-(AMINO-6-CHLORO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL, WHICH IS AN INTERMEDIATE FOR 6-(CYCLOPROPYLAMINO)-DERIVATIVE | LONZA AG (CH) | 2000-10-24 | — | — | US | disclosed |
| EP-0878548-A2 | Multistep process for the preparation of (1S,4R)- and/or (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopentene-1-methanol | LONZA AG (CH) | 1998-11-18 | — | — | EP | disclosed |